Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma
NCT00673010
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Thyroid Cancer
Interventions
RADIATION:
131 I-iodine (131-I), 124 I-iodine (124-I)
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]